News

Press ReleaseKing's College London spins out Korecyte Bio Ltd with investment and support from Cell and Gene Therapy Catapult to advance novel CAR-T platform for solid tumours
Filter:AllPress ReleaseCell TherapiesGene TherapiesDigital and AutomationSpin-outs, Start-ups, Sector investmentManufacturingRegulatory affairsSkills and Training
Year:All2026202520242023 →
Press release: Cell and Gene Therapy Catapult Licenses Cell Culture Data to Ajinomoto Co., Inc.Press release: Cell and Gene Therapy Catapult Licenses Cell Culture Data to Ajinomoto Co., Inc.Regulatory news - May 2017Regulatory news - May 2017Gene-modified T-cells: Going into battleGene-modified T-cells: Going into battleHighlights from ISCT 2017Highlights from ISCT 2017Cynata Therapeutics announce first patient treated in Phase I clinical trialCynata Therapeutics announce first patient treated in Phase I clinical trialStem cell therapies: can anything stop them now?Stem cell therapies: can anything stop them now?ReNeuron awarded major UK cell therapy manufacturing grantReNeuron awarded major UK cell therapy manufacturing grantPress release: Novel cell growth and measurement techniques unveiled at ISCT 2017Press release: Novel cell growth and measurement techniques unveiled at ISCT 2017Regulatory news - April 2017Regulatory news - April 2017Updating our clinical trials and preclinical programmes databasesUpdating our clinical trials and preclinical programmes databasesQuality by design and process automation key for making commercial cell therapiesQuality by design and process automation key for making commercial cell therapiesRegulatory news - March 2017Regulatory news - March 2017